Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @DanBudwick
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @DanBudwick
-
Prikvačeni tweet
Good morning
#JPM20 - EQRx launches to create and deliver innovative medicines at dramatically lower prices for people, healthcare systems and societyhttps://www.eqrx.com/press-release/eqrx-launches-to-create-innovative-medicines-at-dramatically-lower-prices-for-people-healthcare-systems-and-society/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congrats to
@JorgeCondeBio and the team at@a16z!https://twitter.com/JohnCendpts/status/1224665670098595841 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
So I woke up wondering who won the Iowa caucus. Watched this, shook my head, and moved on.https://youtu.be/Z0j7JTeyIlU
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Great to be working together again, Jamie!https://twitter.com/relay_tx/status/1224648976965816320 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Pitchers and catchers in 10 days. LET'S GO
@Yankees!Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Inside the Company That’s Developing the First Coronavirus Vaccine - via
@TIME @AliceParkNY @moderna_tx$MRNAhttps://time.com/5775784/coronavirus-vaccine-research/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@CNBC@chrissyfarr caught up with the founders, investors & mgmt team of Thrive to learn more about its quest to develop a blood test given during well visits to catch multiple cancers.https://twitter.com/chrissyfarr/status/1223659706318753792 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Dan Budwick proslijedio/la je Tweet
$VRTX sold $420 million of Trikafta, its new cystic fibrosis drug, in the fourth quarter. Approval came three weeks into Oct., so that's ~9 weeks of sales.https://investors.vrtx.com/news-releases/news-release-details/vertex-reports-full-year-and-fourth-quarter-2019-financial …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@rubius_tx$RUBY - first patient dosed in Phase 1b trial of RTX-134 for the treatment of people with PKUhttps://ir.rubiustx.com/news-releases/news-release-details/rubius-therapeutics-announces-first-patient-dosed-phase-1b-trial …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
From late last night: Alector
$ALEC announces upsizing and pricing of public offering - gross proceeds of $208Mhttps://investors.alector.com/news-releases/news-release-details/alector-announces-upsizing-and-pricing-public-offering …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dan Budwick proslijedio/la je Tweet
VIDEO: Dr. John DiPersio discusses initial Ph 1 results, demonstrating MGTA-145, combined w/ plerixafor, enables safe, same-day dosing, mobilization & collection of sufficient high-quality HSCs for transplant - more to come at
#TCTM20 in Feb! https://vjhemonc.com/video/li8n6i7ik34-mgta-145-with-plerixafor-induces-rapid-mobilization-of-cd34-hscs/ …@VJHemOncHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@US_FDA announces guidance to provide regulatory clarity for gene therapy developershttps://twitter.com/SteveFDA/status/1222152149502775296 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Alector
$ALEC announces Phase 1b initiation of AL003 in people living with Alzheimer's disease. Alector has developed AL003 to block the inhibitory function of SIGLEC 3, an immune receptor linked to AD https://investors.alector.com/node/7011/pdfHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@Relay_Tx CEO@SanjivKPatel1 on@timmermanreport “The Long Run” with@ldtimmerman! Check it out!https://twitter.com/Relay_Tx/status/1222103288709046272 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dan Budwick proslijedio/la je Tweet
$MRNA: "We're all hopeful this is not a situation that evolves, that the pandemic does not emerge as that kind of threat, but unfortunately hope is not a strategy." Aims to have batch of vaccine ready for NIH ph1 human trial in a few months.#coronavirushttps://twitter.com/Harri8t/status/1221891772642668544 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Interesting story by
@FT@SarahNev, incl how@FoundationATCG &@flatironhealth have combined forces under@Roche's roof, leading to clinical insights contained in vast troves of anonymised patient datahttps://twitter.com/FT/status/1221297384841449473 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dan Budwick proslijedio/la je Tweet
Damn. RIP Mamba. May your memory be a blessing
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dan Budwick proslijedio/la je Tweet
Very proud of Moderna's commitment to addressing infectious diseases and improving global public health!
#mRNAhttps://twitter.com/CBSThisMorning/status/1220679962753224705 …
2:48Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dan Budwick proslijedio/la je Tweet
Congratulations on your retirement, and a great career Eli! Not going to lie though, I wish you hadn’t won any Super Bowls.
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thrive CEO Dave Daly on how the team is thinking about different stakeholders and opportunities as it builds an early cancer detection company.
#PMWC20https://twitter.com/ed_winnick/status/1220417990090424321 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.